Cardiovascular complications of pregnancy

International Journal of Molecular Sciences

Volumn 16, Issue 10, 2015, Pages 23905-23928

  Gongora, Maria Carolina ^a   Wenger, Nanette K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular risk factors; Gestational diabetes; Hypertensive disorders of pregnancy; Preeclampsia; Pregnancy complications

Indexed keywords

BIOLOGICAL MARKER;

CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; ECLAMPSIA AND PREECLAMPSIA; FEMALE; GESTATIONAL AGE; GLUCOSE METABOLISM; HEART FAILURE; HEMODYNAMICS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; MATERNAL WELFARE; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; REVIEW; RISK FACTOR; FETUS DEVELOPMENT; NEWBORN; PATHOPHYSIOLOGY; POSTNATAL CARE; PREECLAMPSIA; PREGNANCY; PREMATURITY; PROCEDURES;

BIOMARKERS; DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; POSTNATAL CARE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREMATURE BIRTH; RISK FACTORS;

EID: 84944112151     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161023905     Document Type: Review

References (133)

1. Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; de Ferranti, S.; Despres, J.P.; Fullerton, H.J.; Howard, V.J. et al. Heart disease and stroke statistics—2015 update: A report from the american heart association. Circulation 2015, 131, e29–e322.
2. Women’s Heart Disease Awareness Study. Available online: https://www.goredforwomen.org/about-heart-disease/facts_about_heart_disease_in_women-sub-category/womens-heart-diseaseawareness- study-2012/ (accessed on 17 September 2015).
3. Bellamy, L.; Casas, J.P.; Hingorani, A.D.; Williams, D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007, 335, doi:10.1136/bmj.39335.385301.BE.
4. Savitz, D.A.; Danilack, V.A.; Elston, B.; Lipkind, H.S. Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am. J. Epidemiol. 2014, 180, 41–44.
5. Cusimano, M.C.; Pudwell, J.; Roddy, M.; Cho, C.K.; Smith, G.N. The maternal health clinic: An initiative for cardiovascular risk identification in women with pregnancy-related complications. Am. J. Obstet. Gynecol. 2014, 210, e431–e439.
6. Pritchard, J.A. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965, 26, 393–399.
7. Van Oppen, A.C.; Stigter, R.H.; Bruinse, H.W. Cardiac output in normal pregnancy: A critical review. Obstet. Gynecol. 1996, 87, 310–318.
8. Curran-Everett, D.; Morris, K.G., Jr.; Moore, L.G. Regional circulatory contributions to increased systemic vascular conductance of pregnancy. Am. J. Physiol. 1991, 261, H1842–H1847.
9. Geva, T.; Mauer, M.B.; Striker, L.; Kirshon, B.; Pivarnik, J.M. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am. Heart J. 1997, 133, 53–59.
10. Chaiworapongsa, T.; Chaemsaithong, P.; Yeo, L.; Romero, R. Pre-eclampsia part 1: Current understanding of its pathophysiology. Nat. Rev. Nephrol. 2014, 10, 466–480.
11. Bulmer, J.N.; Innes, B.A.; Levey, J.; Robson, S.C.; Lash, G.E. The role of vascular smooth muscle cell apoptosis and migration during uterine spiral artery remodeling in normal human pregnancy. FASEB J. 2012, 26, 2975–2985.
12. Li, W.; Mata, K.M.; Mazzuca, M.Q.; Khalil, R.A. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sflt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy. Biochem. Pharmacol. 2014, 89, 370–385.
13. Easterling, T.R.; Benedetti, T.J.; Schmucker, B.C.; Carlson, K.; Millard, S.P. Maternal hemodynamics and aortic diameter in normal and hypertensive pregnancies. Obstet. Gynecol. 1991, 78, 1073–1077.
14. Talbert, L.M.; Langdell, R.D. Normal values of certain factors in the blood clotting mechanism in pregnancy. Am. J. Obstet. Gynecol. 1964, 90, 44–50.
15. Okoroh, E.M.; Azonobi, I.C.; Grosse, S.D.; Grant, A.M.; Atrash, H.K.; James, A.H. Prevention of venous thromboembolism in pregnancy: A review of guidelines, 2000–2011. J. Women’s Health 2012, 21, 611–615.
16. Lussana, F.; Coppens, M.; Cattaneo, M.; Middeldorp, S. Pregnancy-related venous thromboembolism: Risk and the effect of thromboprophylaxis. Thromb. Res. 2012, 129, 673–680.
17. Clark, P.; Brennand, J.; Conkie, J.A.; McCall, F.; Greer, I.A.; Walker, I.D. Activated protein c sensitivity, protein c, protein s and coagulation in normal pregnancy. Thromb. Haemost. 1998, 79, 1166–1170.
18. Brizzi, P.; Tonolo, G.; Esposito, F.; Puddu, L.; Dessole, S.; Maioli, M.; Milia, S. Lipoprotein metabolism during normal pregnancy. Am. J. Obstet. Gynecol. 1999, 181, 430–434.
19. Charlton, F.; Tooher, J.; Rye, K.A.; Hennessy, A. Cardiovascular risk, lipids and pregnancy: Preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ. 2014, 23, 203–212.
20. Emet, T.; Ustuner, I.; Guven, S.G.; Balik, G.; Ural, U.M.; Tekin, Y.B.; Senturk, S.; Sahin, F.K.; Avsar, A.F. Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes. Arch. Gynecol. Obstet. 2013, 288, 49–55.
21. Ghio, A.; Bertolotto, A.; Resi, V.; Volpe, L.; di Cianni, G. Triglyceride metabolism in pregnancy. Adv. Clin. Chem. 2011, 55, 133–153.
22. Duley, L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatal. 2009, 33, 130–137.
23. Ahmed, R.; Dunford, J.; Mehran, R.; Robson, S.; Kunadian, V. Pre-eclampsia and future cardiovascular risk among women: A review. J. Am. Coll. Cardiol. 2014, 63, 1815–1822.
24. Lambert, G.; Brichant, J.F.; Hartstein, G.; Bonhomme, V.; Dewandre, P.Y. Preeclampsia: An update. Acta Anaesthesiol. Belg. 2014, 65, 137–149.
25. Vaughan, J.E.; Walsh, S.W. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens. Pregnancy 2002, 21, 205–223.
26. Gant, N.F.; Chand, S.; Whalley, P.J.; MacDonald, P.C. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet. Gynecol. 1974, 43, 854–860.
27. Romero, R.; Mazor, M.; Lockwood, C.J.; Emamian, M.; Belanger, K.P.; Hobbins, J.C.; Duffy, T. Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension. Am. J. Perinatal. 1989, 6, 32–38.
28. Wei, S.Q.; Audibert, F.; Hidiroglou, N.; Sarafin, K.; Julien, P.; Wu, Y.; Luo, Z.C.; Fraser, W.D. Longitudinal vitamin d status in pregnancy and the risk of pre-eclampsia. BJOG 2012, 119, 832–839.
29. Bodnar, L.M.; Catov, J.M.; Simhan, H.N.; Holick, M.F.; Powers, R.W.; Roberts, J.M. Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 2007, 92, 3517–3522.
30. Slusher, A.L.; McAllister, M.J.; Huang, C.J. A therapeutic role for vitamin d on obesity-associated inflammation and weight-loss intervention. Inflamm. Res. 2015, 64, 565–575.
31. Waterhouse, M.; Tran, B.; Ebeling, P.R.; English, D.R.; Lucas, R.M.; Venn, A.J.; Webb, P.M.; Whiteman, D.C.; Neale, R.E. Effect of vitamin d supplementation on selected inflammatory biomarkers in older adults: A secondary analysis of data from a randomised, placebo-controlled trial. Br. J. Nutr. 2015, 1–7.
32. Redman, C.W.; Sacks, G.P.; Sargent, I.L. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 1999, 180, 499–506.
33. Maynard, S.; Epstein, F.H.; Karumanchi, S.A. Preeclampsia and angiogenic imbalance. Ann. Rev. Med. 2008, 59, 61–78.
34. American College of Obstetricians and Gynecologists. Vitamin D: Screening and supplementation during pregnancy. Obstet. Gynecol. 2011, 118, 297–298.
35. MacKay, A.P.; Berg, C.J.; Atrash, H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 2001, 97, 533–538.
36. Roberts, C.L.; Algert, C.S.; Morris, J.M.; Ford, J.B.; Henderson-Smart, D.J. Hypertensive disorders in pregnancy: A population-based study. Med. J. Aust. 2005, 182, 332–335.
37. Broekhuijsen, K.; Ravelli, A.C.; Langenveld, J.; van Pampus, M.G.; van Den Berg, P.P.; Mol, B.W.; Franssen, M.T. Maternal and neonatal outcomes of pregnancy in women with chronic hypertension: A retrospective analysis of a national register. Acta Obstet. Gynecol. Scand. 2015, doi:10.1111/aogs.12757.
38. Barbosa, I.R.; Silva, W.B.; Cerqueira, G.S.; Novo, N.F.; Almeida, F.A.; Novo, J.L. Maternal and fetal outcome in women with hypertensive disorders of pregnancy: The impact of prenatal care. Ther. Adv. Cardiovasc. Dis. 2015, 9, 140–146.
39. Ramadan, M.M.; Mahfouz, E.M.; Gomaa, G.F.; El-Diasty, T.A.; Alldawi, L.; Ikrar, T.; Limin, D.; Kodama, M.; Aizawa, Y. Evaluation of coronary calcium score by multidetector computed tomography in relation to endothelial function and inflammatory markers in asymptomatic individuals. Circ. J. 2008, 72, 778–785.
40. Budoff, M.J.; Flores, F.; Tsai, J.; Frandsen, T.; Yamamoto, H.; Takasu, J. Measures of brachial artery distensibility in relation to coronary calcification. Am. J. Hypertens. 2003, 16, 350–355.
41. Cassidy-Bushrow, A.E.; Bielak, L.F.; Rule, A.D.; Sheedy, P.F.; Turner, S.T.; Garovic, V.D.; Peyser, P.A. Hypertension during pregnancy is associated with coronary artery calcium independent of renal function. J. Womens Health 2009, 18, 1709–1716.
42. Magnussen, E.B.; Vatten, L.J.; Smith, G.D.; Romundstad, P.R. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet. Gynecol. 2009, 114, 961–970.
43. Garovic, V.D.; Bailey, K.R.; Boerwinkle, E.; Hunt, S.C.; Weder, A.B.; Curb, D.; Mosley, T.H., Jr.; Wiste, H.J.; Turner, S.T. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J. Hypertens. 2010, 28, 826–833.
44. Lykke, J.A.; Langhoff-Roos, J.; Sibai, B.M.; Funai, E.F.; Triche, E.W.; Paidas, M.J. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009, 53, 944–951.
45. Irgens, H.U.; Reisaeter, L.; Irgens, L.M.; Lie, R.T. Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. BMJ 2001, 323, 1213–1217.
46. Jonsdottir, L.S.; Arngrimsson, R.; Geirsson, R.T.; Sigvaldason, H.; Sigfusson, N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet. Gynecol. Scand. 1995, 74, 772–776.
47. Shopen, N.; Schiff, E.; Koren-Morag, N.; Grossman, E. Factors that predict the development of hypertension in women with pregnancy-induced hypertension. Am. J. Hypertens. 2015, in press.
48. Van Walraven, C.; Mamdani, M.; Cohn, A.; Katib, Y.; Walker, M.; Rodger, M.A. Risk of subsequent thromboembolism for patients with pre-eclampsia. BMJ 2003, 326, 791–792.
49. Rodie, V.A.; Freeman, D.J.; Sattar, N.; Greer, I.A. Pre-eclampsia and cardiovascular disease: Metabolic syndrome of pregnancy? Atherosclerosis 2004, 175, 189–202.
50. Marin, R.; Gorostidi, M.; Portal, C.G.; Sanchez, M.; Sanchez, E.; Alvarez, J. Long-term prognosis of hypertension in pregnancy. Hypertens. Pregnancy 2000, 19, 199–209.
51. Hermes, W.; Franx, A.; van Pampus, M.G.; Bloemenkamp, K.W.; Bots, M.L.; van der Post, J.A.; Porath, M.; Ponjee, G.A.; Tamsma, J.T.; Mol, B.W. et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: A cohort study. Am. J. Obstet. Gynecol. 2013, 208, e471–e478.
52. Al-Nasiry, S.; Ghossein-Doha, C.; Polman, S.; Lemmens, S.; Scholten, R.; Heidema, W.; Spaan, J.; Spaanderman, M. Metabolic syndrome after pregnancies complicated by pre-eclampsia or small for gestational age: A retrospective cohort. BJOG Int. J. Obstet. Gynaecol. 2014, doi: 10.1111/1471-0528.13117.
53. Kessous, R.; Shoham-Vardi, I.; Pariente, G.; Sergienko, R.; Sheiner, E. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart 2015, 101, 442–446.
54. Hermes, W.; Tamsma, J.T.; Grootendorst, D.C.; Franx, A.; van der Post, J.; van Pampus, M.G.; Bloemenkamp, K.W.; Porath, M.; Mol, B.W.; de Groot, C.J. Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: A longitudinal follow-up study. BMC Pregnancy Childbirth 2013, 13, doi: 10.1186/1471-2393-13-126.
55. Funai, E.F.; Friedlander, Y.; Paltiel, O.; Tiram, E.; Xue, X.; Deutsch, L.; Harlap, S. Long-term mortality after preeclampsia. Epidemiology 2005, 16, 206–215.
56. Ray, J.G.; Vermeulen, M.J.; Schull, M.J.; Redelmeier, D.A. Cardiovascular health after maternal placental syndromes (champs): Population-based retrospective cohort study. Lancet 2005, 366, 1797–1803.
57. Wu, C.C.; Chen, S.H.; Ho, C.H.; Liang, F.W.; Chu, C.C.; Wang, H.Y.; Lu, Y.H. End-stage renal disease after hypertensive disorders in pregnancy. Am. J. Obstet. Gynecol. 2014, 210, 147 e1–e8.
58. Cirillo, P.M.; Cohn, B.A. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the child health and development studies pregnancy cohort. Circulation 2015, 132, 1234–1242.
59. Aykas, F.; Solak, Y.; Erden, A.; Bulut, K.; Dogan, S.; Sarli, B.; Acmaz, G.; Afsar, B.; Siriopol, D.; Covic, A. et al. Persistence of cardiovascular risk factors in women with previous preeclampsia: A long-term follow-up study. J. Investig. Med. 2015, 63, 641–645.
60. Henriques, A.C.; Carvalho, F.H.; Feitosa, H.N.; Macena, R.H.; Mota, R.M.; Alencar, J.C. Endothelial dysfunction after pregnancy-induced hypertension. Int. J. Gynaecol. Obstet. 2014, 124, 230–234.
61. Ray, J.G.; Schull, M.J.; Kingdom, J.C.; Vermeulen, M.J. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart 2012, 98, 1136–1141.
62. Davey Smith, G.; Hypponen, E.; Power, C.; Lawlor, D.A. Offspring birth weight and parental mortality: Prospective observational study and meta-analysis. Am. J. Epidemiol. 2007, 166, 160–169.
63. Smith, G.D.; Harding, S.; Rosato, M. Relation between infants’ birth weight and mothers’ mortality: Prospective observational study. BMJ 2000, 320, 839–840.
64. Smith, G.D.; Whitley, E.; Gissler, M.; Hemminki, E. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet 2000, 356, 2066–2067.
65. Catov, J.M.; Wu, C.S.; Olsen, J.; Sutton-Tyrrell, K.; Li, J.; Nohr, E.A. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann. Epidemiol. 2010, 20, 604–609.
66. Kessous, R.; Shoham-Vardi, I.; Pariente, G.; Holcberg, G.; Sheiner, E. An association between preterm delivery and long-term maternal cardiovascular morbidity. Am. J. Obstet. Gynecol. 2013, 209, e361–e368.
67. Smith, G.C.; Pell, J.P.; Walsh, D. Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 births. Lancet 2001, 357, 2002–2006.
68. Davey Smith, G.; Hart, C.; Ferrell, C.; Upton, M.; Hole, D.; Hawthorne, V.; Watt, G. Birth weight of offspring and mortality in the renfrew and paisley study: Prospective observational study. BMJ 1997, 315, 1189–1193.
69. Blondon, M.; Quon, B.S.; Harrington, L.B.; Bounameaux, H.; Smith, N.L. Association between newborn birth weight and the risk of postpartum maternal venous thromboembolism: A population-based case-control study. Circulation 2015, 131, 1471–1476.
70. Pariente, G.; Sheiner, E.; Kessous, R.; Michael, S.; Shoham-Vardi, I. Association between delivery of a small-for-gestational-age neonate and long-term maternal cardiovascular morbidity. Int. J. Gynaecol. Obstet. 2013, 123, 68–71.
71. Perng, W.; Stuart, J.; Rifas-Shiman, S.L.; Rich-Edwards, J.W.; Stuebe, A.; Oken, E. Preterm birth and long-term maternal cardiovascular health. Ann. Epidemiol. 2015, 25, 40–45.
72. Ferreira, I.; Peeters, L.L.; Stehouwer, C.D. Preeclampsia and increased blood pressure in the offspring: Meta-analysis and critical review of the evidence. J. Hypertens. 2009, 27, 1955–1959.
73. McDonald, S.D.; Malinowski, A.; Zhou, Q.; Yusuf, S.; Devereaux, P.J. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses. Am. Heart J. 2008, 156, 918–930.
74. Oglaend, B.; Forman, M.R.; Romundstad, P.R.; Nilsen, S.T.; Vatten, L.J. Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies. J. Hypertens. 2009, 27, 2051–2054.
75. Herrera-Garcia, G.; Contag, S. Maternal preeclampsia and risk for cardiovascular disease in offspring. Curr. Hypertens. Rep. 2014, 16, 475, doi:10.1007/s11906-014-0475-3.
76. Palmsten, K.; Buka, S.L.; Michels, K.B. Maternal pregnancy-related hypertension and risk for hypertension in offspring later in life. Obstet. Gynecol. 2010, 116, 858–864.
77. Kaijser, M.; Bonamy, A.K.; Akre, O.; Cnattingius, S.; Granath, F.; Norman, M.; Ekbom, A. Perinatal risk factors for ischemic heart disease: Disentangling the roles of birth weight and preterm birth. Circulation 2008, 117, 405–410.
78. Kenny, L.C.; Black, M.A.; Poston, L.; Taylor, R.; Myers, J.E.; Baker, P.N.; McCowan, L.M.; Simpson, N.A.; Dekker, G.A.; Roberts, C.T. et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: The screening for pregnancy endpoints (scope) international cohort study. Hypertension 2014, 64, 644–652.
79. Kenny, L.C.; Broadhurst, D.I.; Dunn, W.; Brown, M.; North, R.A.; McCowan, L.; Roberts, C.; Cooper, G.J.; Kell, D.B.; Baker, P.N. et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 2010, 56, 741–749.
80. Pare, E.; Parry, S.; McElrath, T.F.; Pucci, D.; Newton, A.; Lim, K.H. Clinical risk factors for preeclampsia in the 21st century. Obstet. Gynecol. 2014, 124, 763–770.
81. Spencer, K.; Cowans, N.J.; Chefetz, I.; Tal, J.; Meiri, H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery doppler pulsatility index as markers of pre-eclampsia. Int. J. Gynaecol. Obstet. 2007, 29, 128–134.
82. Thilaganathan, B.; Ralph, E.; Papageorghiou, A.T.; Melchiorre, K.; Sheldon, J. Raised maternal serum cystatin c: An early pregnancy marker for preeclampsia. Reprod. Sci. 2009, 16, 788–793.
83. Akolekar, R.; Casagrandi, D.; Livanos, P.; Tetteh, A.; Nicolaides, K.H. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat. Diagn. 2009, 29, 934–938.
84. Wikstrom, A.K.; Larsson, A.; Eriksson, U.J.; Nash, P.; Norden-Lindeberg, S.; Olovsson, M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet. Gynecol. 2007, 109, 1368–1374.
85. Holthe, M.R.; Staff, A.C.; Berge, L.N.; Lyberg, T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am. J. Obstet. Gynecol. 2004, 190, 1128–1134.
86. Banzola, I.; Farina, A.; Concu, M.; Sekizawa, A.; Purwosunu, Y.; Strada, I.; Arcelli, D.; Simonazzi, G.; Caramelli, E.; Rizzo, N. Performance of a panel of maternal serum markers in predicting preeclampsia at 11–15 weeks’ gestation. Prenat. Diagn. 2007, 27, 1005–1010.
87. D’Anna, R.; Baviera, G.; Giordano, D.; Todarello, G.; Russo, S.; Recupero, S.; Bolignano, D.; Corrado, F. Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet. Gynecol. Scand. 2010, 89, 275–278.
88. Meinila, J.; Koivusalo, S.B.; Valkama, A.; Rono, K.; Erkkola, M.; Kautiainen, H.; Stach-Lempinen, B.; Eriksson, J.G. Nutrient intake of pregnant women at high risk of gestational diabetes. Food Nutr. Res. 2015, 59, doi:10.3402/fnr.v59.26676.
89. Schneider, S.; Bock, C.; Wetzel, M.; Maul, H.; Loerbroks, A. The prevalence of gestational diabetes in advanced economies. J. Perinat. Med. 2012, 40, 511–520.
90. Rieck, S.; Kaestner, K.H. Expansion of β-cell mass in response to pregnancy. Trends Endocrinol. Metab. 2010, 21, 151–158.
91. Brewster, S.; Zinman, B.; Retnakaran, R.; Floras, J.S. Cardiometabolic consequences of gestational dysglycemia. J. Am. Coll. Cardiol. 2013, 62, 677–684.
92. Carr, D.B.; Utzschneider, K.M.; Hull, R.L.; Tong, J.; Wallace, T.M.; Kodama, K.; Shofer, J.B.; Heckbert, S.R.; Boyko, E.J.; Fujimoto, W.Y. et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006, 29, 2078–2083.
93. Retnakaran, R.; Shah, B.R. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: A population-based cohort study. Can. Med. Assoc. J. 2009, 181, 371–376.
94. Lee, A.J.; Hiscock, R.J.; Wein, P.; Walker, S.P.; Permezel, M. Gestational diabetes mellitus: Clinical predictors and long-term risk of developing type 2 diabetes: A retrospective cohort study using survival analysis. Diabetes Care 2007, 30, 878–883.
95. Kaufmann, R.C.; Schleyhahn, F.T.; Huffman, D.G.; Amankwah, K.S. Gestational diabetes diagnostic criteria: Long-term maternal follow-up. Am. J. Obstet. Gynecol. 1995, 172, 621–625.
96. Feig, D.S.; Zinman, B.; Wang, X.; Hux, J.E. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. Can. Med. Assoc. J. 2008, 179, 229–234.
97. Kim, C.; Newton, K.M.; Knopp, R.H. Gestational diabetes and the incidence of type 2 diabetes: A systematic review. Diabetes Care 2002, 25, 1862–1868.
98. American Diabetes, A. Gestational diabetes mellitus. Diabetes Care 2000, 23 (Suppl. 1), S77–S79.
99. Karoli, R.; Siddiqi, Z.; Fatima, J.; Shukla, V.; Mishra, P.P.; Khan, F.A. Assessment of noninvasive risk markers of subclinical atherosclerosis in premenopausal women with previous history of gestational diabetes mellitus. Heart Views 2015, 16, 13–18.
100. Lauenborg, J.; Mathiesen, E.; Hansen, T.; Glumer, C.; Jorgensen, T.; Borch-Johnsen, K.; Hornnes, P.; Pedersen, O.; Damm, P. The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J. Clin. Endocrinol. Metab. 2005, 90, 4004–4010.
101. Retnakaran, R.; Qi, Y.; Connelly, P.W.; Sermer, M.; Zinman, B.; Hanley, A.J. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J. Clin. Endocrinol. Metab. 2010, 95, 670–677.
102. Retnakaran, R.; Qi, Y.; Connelly, P.W.; Sermer, M.; Hanley, A.J.; Zinman, B. The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein b in young women: Implications for future cardiovascular risk. J. Clin. Endocrinol. Metab. 2010, 95, 4345–4353.
103. Freire, C.M.; Barbosa, F.B.; de Almeida, M.C.; Miranda, P.A.; Barbosa, M.M.; Nogueira, A.I.; Guimaraes, M.M.; Nunes Mdo, C.; Ribeiro-Oliveira, A. Jr. Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome—a case control study. Cardiovasc. Diabetol. 2012, 11, doi:10.1186/1475-2840-11-59.
104. Gunderson, E.P.; Chiang, V.; Pletcher, M.J.; Jacobs, D.R.; Quesenberry, C.P.; Sidney, S.; Lewis, C.E. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: The coronary artery risk development in young adults study. J. Am. Heart Assoc. 2014, 3, doi:10.1161/JAHA.113.000490.
105. Dawson, S.I. Glucose tolerance in pregnancy and the long-term risk of cardiovascular disease. Diabetes Res. Clin. Pract. 2009, 85, 14–19.
106. Fadl, H.; Magnuson, A.; Ostlund, I.; Montgomery, S.; Hanson, U.; Schwarcz, E. Gestational diabetes mellitus and later cardiovascular disease: A swedish population based case-control study. BJOG Int. J. Obstet. Gynaecol. 2014, 121, 1530–1536.
107. Kim, C.; Cheng, Y.J.; Beckles, G.L. Cardiovascular disease risk profiles in women with histories of gestational diabetes but without current diabetes. Obstet. Gynecol. 2008, 112, 875–883.
108. North, R.A.; McCowan, L.M.; Dekker, G.A.; Poston, L.; Chan, E.H.; Stewart, A.W.; Black, M.A.; Taylor, R.S.; Walker, J.J.; Baker, P.N. et al. Clinical risk prediction for pre-eclampsia in nulliparous women: Development of model in international prospective cohort. BMJ 2011, 342, doi:10.1136/bmj.d1875.
109. Campbell, S.; Diaz-Recasens, J.; Griffin, D.R.; Cohen-Overbeek, T.E.; Pearce, J.M.; Willson, K.; Teague, M.J. New doppler technique for assessing uteroplacental blood flow. Lancet 1983, 1, 675–677.
110. Duckitt, K.; Harrington, D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ 2005, 330, 565.
111. Cnossen, J.S.; Vollebregt, K.C.; de Vrieze, N.; ter Riet, G.; Mol, B.W.; Franx, A.; Khan, K.S.; van der Post, J.A. Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: Systematic review and meta-analysis. BMJ 2008, 336, 1117–1120.
112. Wright, A.; Wright, D.; Ispas, C.A.; Poon, L.C.; Nicolaides, K.H. Mean arterial pressure in the three trimesters of pregnancy: Effects of maternal characteristics and medical history. Int. J. Gynaecol. Obstet. 2015, 45, 698–706.
113. Napolitano, R.; Rajakulasingam, R.; Memmo, A.; Bhide, A.; Thilaganathan, B. Uterine artery doppler screening for pre-eclampsia: Comparison of the lower, mean and higher first-trimester pulsatility indices. Int. J. Gynaecol. Obstet. 2011, 37, 534–537.
114. Allen, R.; Rogozinska, E.; Sivarajasingam, P.; Khan, K.S.; Thangaratinam, S. Effect of diet- and lifestyle-based metabolic risk-modifying interventions on preeclampsia: A meta-analysis. Acta Obstet. Gynecol. Scand. 2014, 93, 973–985.
115. Duley, L.; Henderson-Smart, D.J.; Meher, S.; King, J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst. Rev. 2007, 2, doi:10.1002/14651858.CD004659.
116. Askie, L.M.; Duley, L.; Henderson-Smart, D.J.; Stewart, L.A.; Group, P.C. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 2007, 369, 1791–1798.
117. Bujold, E.; Roberge, S.; Lacasse, Y.; Bureau, M.; Audibert, F.; Marcoux, S.; Forest, J.C.; Giguere, Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet. Gynecol. 2010, 116, 402–414.
118. Villa, P.M.; Kajantie, E.; Raikkonen, K.; Pesonen, A.K.; Hamalainen, E.; Vainio, M.; Taipale, P.; Laivuori, H. Aspirin in the prevention of pre-eclampsia in high-risk women. BJOG Int. J. Obstet. Gynaecol. 2013, 120, doi:10.1111/1471-0528.12135.
119. Roberge, S.; Nicolaides, K.H.; Demers, S.; Villa, P.; Bujold, E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A meta-analysis. Int. J. Gynaecol. Obstet. 2013, 41, 491–499.
120. Hofmeyr, G.J.; Lawrie, T.A.; Atallah, A.N.; Duley, L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst. Rev. 2010, doi:10.1002/14651858.CD001059.pub2.
121. Robbins, C.L.; Dietz, P.M.; Bombard, J.; Valderrama, A.L. Gestational hypertension: A neglected cardiovascular disease risk marker. Am. J. Obstet. Gynecol. 2011, 204, e331–e339.
122. Ehrenthal, D.B.; Maiden, K.; Rogers, S.; Ball, A. Postpartum healthcare after gestational diabetes and hypertension. J. Womens Health 2014, 23, 760–764.
123. Mosca, L.; Benjamin, E.J.; Berra, K.; Bezanson, J.L.; Dolor, R.J.; Lloyd-Jones, D.M.; Newby, L.K.; Pina, I.L.; Roger, V.L.; Shaw, L.J. et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: A guideline from the american heart association. Circulation 2011, 123, 1243–1262.
124. Catov, J.M. Pregnancy as a window to cardiovascular disease risk: How will we know? J. Womens Health 2015, 24, 691–692.
125. Berks, D.; Hoedjes, M.; Raat, H.; Duvekot, H.J.; Steegers, E.A. (68-or): Effects of lifestyle intervention after complicated pregnancy: Results of the pro-active study. Pregnancy Hypertens. 2015, 5, 36–37.
126. Berks, D.; Hoedjes, M.; Raat, H.; Duvekot, J.J.; Steegers, E.A.; Habbema, J.D. Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: A literature-based study. BJOG Int. J. Obstet. Gynaecol. 2013, 120, 924–931.
127. Ratner, R.E.; Christophi, C.A.; Metzger, B.E.; Dabelea, D.; Bennett, P.H.; Pi-Sunyer, X.; Fowler, S.; Kahn, S.E.; Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: Effects of metformin and lifestyle interventions. J. Clin. Endocrinol. Metab. 2008, 93, 4774–4779.
128. Veerbeek, J.H.; Hermes, W.; Breimer, A.Y.; van Rijn, B.B.; Koenen, S.V.; Mol, B.W.; Franx, A.; de Groot, C.J.; Koster, M.P. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension 2015, 65, 600–606.
129. Verbeek, A.L.; Verbeek, A.J. Timely assessment of cardiovascular risk after preeclampsia. J. Womens Health 2014, 10, 557–559.
130. Janmohamed, R.; Montgomery-Fajic, E.; Sia, W.; Germaine, D.; Wilkie, J.; Khurana, R.; Nerenberg, K.A. Cardiovascular risk reduction and weight management at a hospital-based postpartum preeclampsia clinic. J. Obstet. Gynaecol. Can. 2015, 37, 330–337.
131. Philis-Tsimikas, A.; Fortmann, A.L.; Dharkar-Surber, S.; Euyoque, J.A.; Ruiz, M.; Schultz, J.; Gallo, L.C. Dulce mothers: An intervention to reduce diabetes and cardiovascular risk in latinas after gestational diabetes. Transl. Behave Med. 2014, 4, 18–25.
132. Spaan, J.; Peeters, L.; Spaanderman, M.; Brown, M. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension 2012, 60, 1368–1373.
133. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM); Regitz-Zagrosek, V.; Blomstrom Lundqvist, C.; Borghi, C.; Cifkova, R.; Ferreira, R.; Foidart, J.M.; Gibbs, J.S. et al. Esc guidelines on the management of cardiovascular diseases during pregnancy: The task force on the management of cardiovascular diseases during pregnancy of the european society of cardiology (esc). Eur. Heart J. 2011, 32, 3147–3197.